Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adults With Neovascular Age-related Macular Degeneration”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295
Large-scale testing (Phase 3)Looking for participantsNCT07007065
What this trial is testing

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
AbbVie 561
Not applicableWithdrawnNCT06398080
What this trial is testing

An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Wet Age-related Macular Degeneration (AMD)Diabetic Macular Edema (DME)+1 more
Regeneron Pharmaceuticals
Early research (Phase 1)Study completedNCT07484074
What this trial is testing

A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324

Who this might be right for
Diabetic Macular Edema (DME)Neovascular (Wet) Age-Related Macular Degeneration
Ollin Biosciences, Inc. 164
Large-scale testing (Phase 3)Looking for participantsNCT07064759
What this trial is testing

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
4D Molecular Therapeutics 480
Testing effectiveness (Phase 2)Looking for participantsNCT05197270
What this trial is testing

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
4D Molecular Therapeutics 215
Large-scale testing (Phase 3)Not Yet RecruitingNCT07520318
What this trial is testing

This is a 96-week, Multicenter Study in Patients With Neovascular AMD That Evaluates OCUL101 for Efficacy, Safety, Durability, and Pharmacokinetics, Comparing it With Another Treatment. The Study Will be Conducted in Two Parts, Part A and Part B.

Who this might be right for
Adults With Neovascular Age-related Macular Degeneration
Shenzhen Oculgen Biomedical Technology Co., Ltd. 255
Testing effectiveness (Phase 2)Study completedNCT00612456
What this trial is testing

To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD

Who this might be right for
Macular Degeneration
GlaxoSmithKline 70
Testing effectiveness (Phase 2)Study completedNCT07501052
What this trial is testing

Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy

Who this might be right for
Neovascular (Wet) Age-Related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema+1 more
Sam Chun Dang Pharm. Co. Ltd. 33
Post-approval studies (Phase 4)Study completedNCT06591598
What this trial is testing

Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

Who this might be right for
Diabetic Macular EdemaNeovascular Age-related Macular Degeneration
Bayer 51
Large-scale testing (Phase 3)Active Not RecruitingNCT06491914
What this trial is testing

A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-Related Macular DegenerationDiabetic Macular Edema
Regeneron Pharmaceuticals 1,118
Testing effectiveness (Phase 2)Looking for participantsNCT06660667
What this trial is testing

A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Sanofi 66
Large-scale testing (Phase 3)Active Not RecruitingNCT06864988
What this trial is testing

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Macular Neovascularization Secondary to Age-Related Macular Degeneration
4D Molecular Therapeutics 480
Not applicableStudy completedNCT06769412
What this trial is testing

A Real-World Evidence Study for the Incidence of Retinal Vasculitis (RV) Among Adult Patients Receiving Aflibercept 2 mg in the United States (US)

Who this might be right for
Retinal Vasculitis
Regeneron Pharmaceuticals 550,000
Early research (Phase 1)Active Not RecruitingNCT01736059
What this trial is testing

Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

Who this might be right for
Non-exudative Age-related Macular DegenerationDiabetic RetinopathyRetina Vein Occlusion+2 more
University of California, Davis 15
Large-scale testing (Phase 3)Study completedNCT04239027
What this trial is testing

Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Novartis Pharmaceuticals 210